L. B. Brønden, S. S. Nielsen, N. Toft, and A. T. Kristensen, Data from the Danish veterinary cancer registry on the occurrence and distribution of neoplasms in dogs in Denmark, Vet Rec, vol.166, pp.586-90, 2010.

A. Egenvall, B. N. Bonnett, P. Ohagen, P. Olson, A. Hedhammar et al., Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002, Prev Vet Med, vol.69, pp.109-136, 2005.

D. F. Merlo, L. Rossi, C. Pellegrino, M. Ceppi, U. Cardellino et al., Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy, J Vet Intern Med, vol.22, pp.976-84, 2008.

L. F. Gundim, C. P. De-araújo, W. T. Blanca, E. C. Guimarães, and A. A. Medeiros, Clinical staging in bitches with mammary tumors: influence of type and histological grade, Can J Vet Res, vol.80, pp.318-340, 2016.

T. Yamagami, T. Kobayashi, K. Takahashi, and M. Sugiyama, Prognosis for canine malignant mammary tumors based on TNM and histologic classification, J Vet Med Sci, vol.58, pp.1079-83, 1996.

K. U. Sorenmo, D. R. Woerley, and M. H. Goldschmidt, Withrow and MacEwen's Small Animal Clinical Oncology, pp.538-556, 2012.

, Veterinary Public Health Unit and WHO Collaborating Center for Comparative Oncology, TNM Classification of Tumours in Domestic Animals. World Health Organization, 1980.

S. C. Chang, C. C. Chang, T. J. Chang, and M. L. Wong, Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases, J Am Vet Med Assoc, vol.227, pp.1625-1634, 1998.

L. Peña, P. J. De-andrés, M. Clemente, P. Cuesta, and M. D. Pérez-alenza, Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics, Vet Pathol, vol.50, pp.94-105, 2013.

J. C. Philibert, P. W. Snyder, N. Glickman, L. T. Glickman, D. W. Knapp et al., Influence of host factors on survival in dogs with malignant mammary gland tumors, J Vet Intern Med, vol.17, pp.102-108, 2003.

C. M. Tran, A. S. Moore, and A. E. Frimberger, Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy, Vet Comp Oncol, vol.14, pp.252-62, 2016.

M. Karayannopoulou, E. Kaldrymidou, T. C. Constantinidis, and A. Dessiris, Adjuvant post-operative chemotherapy in bitches with mammary cancer, J Vet Med A Physiol Pathol Clin Med, vol.48, pp.85-96, 2001.

W. ?opuszynski, M. Szczubia?, Y. Millán, S. Guil-luna, R. Sánchez-céspedes et al., Immunohistochemical expression of p63 protein and calponin in canine mammary tumours, Res Vet Sci, vol.123, pp.232-240, 2019.

L. Peña, A. Gama, M. H. Goldschmidt, J. Abadie, C. Benazzi et al., Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry, Vet Pathol, vol.51, pp.127-172, 2014.

R. Sánchez-céspedes, Y. Millán, S. Guil-luna, J. García-monterde, C. Reymundo et al., Myoepithelial cell layer integrity in canine mammary carcinoma, J Comp Pathol, vol.145, pp.25-30, 2011.

R. Sánchez-céspedes, A. Suárez-bonnet, Y. Millán, S. Guil-luna, C. Reymundo et al., Use of CD10 as a marker of canine mammary myoepithelial cells, Vet J, vol.195, pp.192-201, 2013.

R. J. Lee, L. A. Vallow, S. A. Mclaughlin, K. S. Tzou, S. L. Hines et al., Ductal carcinoma in situ of the breast, Int J Surg Oncol, p.123549, 2012.

, Available online at, American Joint Committee on Cancer. Breast Cancer Staging, 2009.

F. Nguyen, L. Peña, C. Ibisch, D. Loussouarn, A. Gama et al., Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors, Breast Cancer Res Treat, vol.167, pp.635-683, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01629625

A. F. Coleto, T. M. Wilson, N. P. Soares, L. F. Gundim, I. P. Castro et al., Prognostic value of occult isolated tumour cells within regional lymph nodes of dogs with malignant mammary tumours, J Comp Pathol, vol.158, pp.32-40, 2018.

M. Szczubia? and W. ?opuszynski, Prognostic value of regional lymph node status in canine mammary carcinomas, Vet Comp Oncol, vol.9, pp.296-303, 2011.

J. L. Tuohy, J. Milgram, D. R. Worley, and W. S. Dernell, A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology, Vet Comp Oncol, vol.7, pp.81-91, 2009.

M. E. Diessler, M. C. Castellano, E. L. Portiansky, S. Burns, and J. R. Idiart, Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time, Vet Comp Oncol, vol.15, pp.450-61, 2017.

F. Sassi, C. Benazzi, G. Castellani, and G. Sarli, Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry, BMC Vet Res, vol.6, p.5, 2010.

J. Abadie, F. Nguyen, D. Loussouarn, L. Peña, A. Gama et al., Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance, Breast Cancer Res Treat, vol.167, pp.459-68, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01629625

M. Goldschmidt, L. Peña, R. Rasotto, and V. Zappulli, Classification and grading of canine mammary tumors, Vet Pathol, vol.48, pp.117-148, 2011.

A. Canadas, M. França, C. Pereira, R. Vilaça, H. Vilhena et al., Canine mammary tumors: comparison of classification and grading methods in a survival study, Vet Pathol, vol.56, pp.208-227, 2019.

M. M. Shamloula, S. H. El-shorbagy, and E. M. Saied, P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma, J Egypt Natl Canc Inst, vol.19, pp.202-212, 2007.

A. J. Matos, A. M. Faustino, C. Lopes, G. R. Rutteman, and F. Gärtner, Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining, Vet Rec, vol.158, pp.626-656, 2006.

A. Gama, F. Gärtner, A. Alves, and F. Schmitt, Immunohistochemical expression of epidermal growth factor receptor (EGFR) in canine mammary tissues, Res Vet Sci, vol.87, pp.432-439, 2009.

E. A. Rakha, M. E. El-sayed, A. R. Green, E. C. Paish, A. H. Lee et al., Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression, Histopathology, vol.50, pp.434-442, 2007.

M. Ono, H. Tsuda, M. Yunokawa, K. Yonemori, C. Shimizu et al., Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers, Breast Cancer, vol.22, pp.141-52, 2015.

F. Penault-llorca and N. Radosevic-robin, Ki67 assessment in breast cancer: an update, Pathology, vol.49, pp.166-171, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01675161

A. C. Wolff, M. E. Hammond, D. G. Hicks, M. Dowsett, L. M. Mcshane et al., Recommendations for human epidermal growth factor receptor 2 testing in breast cancer, Arch Pathol Lab Med, vol.138, pp.241-56, 2014.

D. Betz, D. Schoenrock, R. Mischke, W. Baumgärtner, and I. Nolte, Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre-and postoperatively available information, Tierarztl Prax Ausg K Kleintiere Heimtiere, vol.40, pp.235-277, 2012.

A. Espinosa-los-de-monteros, M. Y. Millán, J. Ordás, L. Carrasco, and C. Reymundo, Martín Las de Mulas J. Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium, Vet Pathol, vol.39, pp.247-56, 2002.

A. Gama, A. Alves, F. Gartner, and F. Schmitt, p63: a novel myoepithelial cell marker in canine mammary tissues, Vet Pathol, vol.40, pp.412-432, 2003.

R. Sánchez-céspedes, Y. Millán, S. Guil-luna, and C. Reymundo, Espinosa de Los Monteros A, Martín de Las Mulas J. Myoepithelial cells in canine mammary tumours, Vet J, vol.207, pp.45-52, 2016.

A. Bailey, G. Layne, C. Shahan, J. Zhang, S. Wen et al., Comparison between ultrasound and pathologic status of axillary lymph nodes in clinically node-negative breast cancer patients, Am Surg, vol.81, pp.865-874, 2015.

J. S. Liikanen, M. H. Leidenius, H. Joensuu, J. H. Vironen, and T. J. Meretoja, Prognostic value of isolated tumour cells in sentinel lymph nodes in early-stage breast cancer: a prospective study, Br J Cancer, vol.118, pp.1529-1564, 2018.

J. E. Somner, J. M. Dixon, and J. S. Thomas, Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status, J Clin Pathol, vol.57, pp.845-853, 2004.

E. A. Mittendorf, A. A. Sahin, S. L. Tucker, F. Meric-bernstam, M. Yi et al., Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients, Ann Surg Oncol, vol.15, pp.3369-77, 2008.

A. E. Giuliano, J. L. Connolly, S. B. Edge, E. A. Mittendorf, H. S. Rugo et al., Breast cancer-major changes in the American joint committee on cancer eighth edition cancer staging manual, CA Cancer J Clin, vol.67, pp.290-303, 2017.

J. Koh and M. J. Kim, Introduction of a new staging system of breast cancer for radiologists: an emphasis on the prognostic stage, Korean J Radiol, vol.20, pp.69-82, 2019.